GLP-1 Medication Side Effects: What to Expect and How to Manage

What are GLP-1 medications and how do they cause side effects?

GLP-1 receptor agonists mimic a naturally occurring gut hormone (glucagon-like peptide-1) that slows gastric emptying, reduces appetite, and helps regulate blood sugar. These effects are why the medications work for diabetes management and weight loss — but slowing how quickly food leaves your stomach is also the primary reason they cause nausea and other digestive symptoms.

Semaglutide (brand names Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound, which also mimics GIP, a second gut hormone) are the most prescribed in this class. In large clinical trials, semaglutide produced substantial average weight loss in adults with obesity 1Ref 1Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF (2021).Once-Weekly Semaglutide in Adults with Overweight or Obesity.Semaglutide efficacy and GI side effect profile in the STEP 1 trial of adults with overweight or obesity, and tirzepatide showed similar or greater effects in its trials 2Ref 2Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A (2022).Tirzepatide Once Weekly for the Treatment of Obesity.Tirzepatide efficacy and GI side effect profile in the SURMOUNT-1 trial. Gastrointestinal side effects were the most common reason participants discontinued these medications.

What are the most common side effects?

The most frequently reported gastrointestinal side effects, as documented in prescribing information and clinical trials, include 3Ref 3Novo Nordisk (2024).WEGOVY (semaglutide) injection — FDA Prescribing Information.Most common GI side effects from prescribing information including nausea, vomiting, diarrhea, constipation; thyroid C-cell tumor precaution4Ref 4Eli Lilly (2022).MOUNJARO (tirzepatide) injection — FDA Prescribing Information.Tirzepatide GI side effect profile from FDA prescribing information:

• Nausea — the most common, affecting a significant proportion of users, especially early in treatment
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain or bloating
• Decreased appetite — which is partly the intended effect but can feel unpleasant
• Burping or acid reflux — due to slowed gastric emptying

Fatigue and headache are also reported by some people, particularly in the early weeks. These effects are most common when the dose is first started or increased, and they generally improve over time for most people.

How long does the nausea last?

For most people, nausea is most intense during the first four to eight weeks of treatment, especially after a dose increase. The standard approach for all medications in this class is to start at a low dose and increase gradually — typically every four weeks — to allow your body to adjust. This titration schedule is specifically designed to reduce gastrointestinal symptoms.

Many people find that nausea improves significantly after the first few weeks at a given dose. However, some continue to experience it intermittently throughout treatment, particularly after eating large or high-fat meals. A smaller number of people find the nausea intolerable enough to stop the medication.

Practical strategies to manage nausea and digestive symptoms

Several approaches can reduce the impact of GLP-1 side effects without stopping the medication:

Eating habits: - Eat smaller meals — your stomach empties more slowly on these medications, so large meals are more likely to cause nausea and discomfort - Eat slowly and stop when you feel full - Avoid high-fat, greasy, or spicy foods, especially around the time of your injection - Avoid eating large amounts right before bed

Staying hydrated: - Sip water or clear fluids throughout the day - If you are vomiting, focus on electrolyte-containing drinks to avoid dehydration

Timing and position: - Try giving your injection at a time when gastrointestinal side effects will be least disruptive (some people prefer evening injections so nausea is during sleep) - Avoid lying down immediately after eating

Constipation: - Increase dietary fiber gradually - Stay well hydrated - Light physical activity helps keep things moving

If symptoms are severe, your prescriber may recommend slowing the dose escalation — staying at a lower dose longer before increasing. This is a common and safe approach.

Are there any serious side effects to know about?

Serious side effects are uncommon but important to recognize:

Pancreatitis. Cases of acute pancreatitis have been reported with GLP-1 medications. Symptoms include severe abdominal pain that may radiate to the back, often with nausea and vomiting. If you develop this pattern of pain, stop the medication and seek medical care promptly.

Gallbladder disease. Rapid weight loss from any cause (including these medications) increases the risk of gallstones. Gallbladder problems — including gallstones and gallbladder inflammation — have been reported in clinical trials.

Possible thyroid concerns. Animal studies showed thyroid C-cell tumors with GLP-1 medications at very high doses, leading to a boxed warning in the prescribing information for a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2). This remains a precaution; the relevance to humans at therapeutic doses is not established, but people with these conditions should not use these medications 3Ref 3Novo Nordisk (2024).WEGOVY (semaglutide) injection — FDA Prescribing Information.Most common GI side effects from prescribing information including nausea, vomiting, diarrhea, constipation; thyroid C-cell tumor precaution.

Kidney-related concerns. Severe nausea, vomiting, and diarrhea can lead to dehydration, which can affect kidney function, particularly in people already on medications for blood pressure. Stay well hydrated and contact your care team if you cannot keep fluids down.

Hair loss. Temporary hair thinning (telogen effluvium) related to rapid weight loss has been reported, though it is not caused by the medication directly — it is a known effect of significant calorie restriction and weight loss from any cause.

What about weight regain if I stop the medication?

This is a reality that is important to discuss openly before starting. Research has shown that when semaglutide is discontinued, much of the weight lost tends to return over the following months 5Ref 5Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF (2022).Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.Weight regain following semaglutide discontinuation in the STEP 1 trial extension. These medications appear to work as long as they are taken — they address the biological drivers of weight regulation, not the underlying cause.

This does not mean you should stay on the medication indefinitely without question, but it does mean stopping without a plan carries a meaningful risk of weight regain. A conversation with your prescribing clinician about long-term strategy — including what exit criteria look like — is an important part of starting treatment.

When should I contact my clinician?

Reach out to your prescribing clinician if: - Nausea or vomiting is severe enough that you cannot eat or drink - You have abdominal pain that does not resolve - You develop symptoms of dehydration (very dark urine, dizziness, rapid heart rate) - You notice significant changes in your mood or vision

A Gale primary care clinician can help you manage GLP-1 side effects, adjust your dose schedule, and discuss whether the medication is the right long-term approach for your goals.